866-997-4948(US-Canada Toll Free)

United States Dendritic Cell Cancer Vaccine Market Report 2016

Published By :

QYResearch

Published Date : Nov 2016

Category :

Cancer

No. of Pages : 110 Pages

Notes:
Sales, means the sales volume of Dendritic Cell Cancer Vaccine
Revenue, means the sales value of Dendritic Cell Cancer Vaccine

This report studies sales (consumption) of Dendritic Cell Cancer Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
3M Company
Activartis
Batavia Bioservices
Creagene
Dendreon
Merck
Northwest Biotherapeutics
Glaxo Smith Kline
ImmunoCellular Therapeutics
Tella Incorporation


Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
CreaVax
Dendritic Cell Activated Cytokine Induced Killer Cells (DC-CIK)
Provenge
Split by applications, this report focuses on sales, market share and growth rate of Dendritic Cell Cancer Vaccine in each application, can be divided into
Application 1
Application 2
Application 3

Table of Contents

United States Dendritic Cell Cancer Vaccine Market Report 2016
1 Dendritic Cell Cancer Vaccine Overview
1.1 Product Overview and Scope of Dendritic Cell Cancer Vaccine
1.2 Classification of Dendritic Cell Cancer Vaccine
1.2.11 CreaVax
1.2.12 Dendritic Cell Activated Cytokine Induced Killer Cells (DC-CIK)
1.2.13 Provenge
1.3 Application of Dendritic Cell Cancer Vaccine
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Dendritic Cell Cancer Vaccine (2011-2021)
1.4.1 United States Dendritic Cell Cancer Vaccine Sales and Growth Rate (2011-2021)
1.4.2 United States Dendritic Cell Cancer Vaccine Revenue and Growth Rate (2011-2021)

2 United States Dendritic Cell Cancer Vaccine Competition by Manufacturers
2.1 United States Dendritic Cell Cancer Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Dendritic Cell Cancer Vaccine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Dendritic Cell Cancer Vaccine Average Price by Manufactures (2015 and 2016)
2.4 Dendritic Cell Cancer Vaccine Market Competitive Situation and Trends
2.4.1 Dendritic Cell Cancer Vaccine Market Concentration Rate
2.4.2 Dendritic Cell Cancer Vaccine Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Dendritic Cell Cancer Vaccine Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Dendritic Cell Cancer Vaccine Sales and Market Share by Type (2011-2016)
3.2 United States Dendritic Cell Cancer Vaccine Revenue and Market Share by Type (2011-2016)
3.3 United States Dendritic Cell Cancer Vaccine Price by Type (2011-2016)
3.4 United States Dendritic Cell Cancer Vaccine Sales Growth Rate by Type (2011-2016)

4 United States Dendritic Cell Cancer Vaccine Sales (Volume) by Application (2011-2016)
4.1 United States Dendritic Cell Cancer Vaccine Sales and Market Share by Application (2011-2016)
4.2 United States Dendritic Cell Cancer Vaccine Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 United States Dendritic Cell Cancer Vaccine Manufacturers Profiles/Analysis
5.1 3M Company
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 3M Company Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Activartis
5.2.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Activartis Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Batavia Bioservices
5.3.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Batavia Bioservices Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Creagene
5.4.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Creagene Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Dendreon
5.5.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Dendreon Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Merck
5.6.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Merck Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Northwest Biotherapeutics
5.7.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Glaxo Smith Kline
5.8.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Glaxo Smith Kline Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 ImmunoCellular Therapeutics
5.9.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Tella Incorporation
5.10.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Tella Incorporation Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview


6 Dendritic Cell Cancer Vaccine Manufacturing Cost Analysis
6.1 Dendritic Cell Cancer Vaccine Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Dendritic Cell Cancer Vaccine

7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Dendritic Cell Cancer Vaccine Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Dendritic Cell Cancer Vaccine Major Manufacturers in 2015
7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List

9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 United States Dendritic Cell Cancer Vaccine Market Forecast (2016-2021)
10.1 United States Dendritic Cell Cancer Vaccine Sales, Revenue Forecast (2016-2021)
10.2 United States Dendritic Cell Cancer Vaccine Sales Forecast by Type (2016-2021)
10.3 United States Dendritic Cell Cancer Vaccine Sales Forecast by Application (2016-2021)
10.4 Dendritic Cell Cancer Vaccine Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Dendritic Cell Cancer Vaccine
Table Classification of Dendritic Cell Cancer Vaccine
Figure United States Sales Market Share of Dendritic Cell Cancer Vaccine by Type in 2015
Figure CreaVax Picture
Figure Dendritic Cell Activated Cytokine Induced Killer Cells (DC-CIK) Picture
Figure Provenge Picture
Table Application of Dendritic Cell Cancer Vaccine
Figure United States Sales Market Share of Dendritic Cell Cancer Vaccine by Application in 2015
Figure United States Dendritic Cell Cancer Vaccine Sales and Growth Rate (2011-2021)
Figure United States Dendritic Cell Cancer Vaccine Revenue and Growth Rate (2011-2021)
Table United States Dendritic Cell Cancer Vaccine Sales of Key Manufacturers (2015 and 2016)
Table United States Dendritic Cell Cancer Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Dendritic Cell Cancer Vaccine Sales Share by Manufacturers
Figure 2016 Dendritic Cell Cancer Vaccine Sales Share by Manufacturers
Table United States Dendritic Cell Cancer Vaccine Revenue by Manufacturers (2015 and 2016)
Table United States Dendritic Cell Cancer Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Dendritic Cell Cancer Vaccine Revenue Share by Manufacturers
Table 2016 United States Dendritic Cell Cancer Vaccine Revenue Share by Manufacturers
Table United States Market Dendritic Cell Cancer Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Dendritic Cell Cancer Vaccine Average Price of Key Manufacturers in 2015
Figure Dendritic Cell Cancer Vaccine Market Share of Top 3 Manufacturers
Figure Dendritic Cell Cancer Vaccine Market Share of Top 5 Manufacturers
Table United States Dendritic Cell Cancer Vaccine Sales by Type (2011-2016)
Table United States Dendritic Cell Cancer Vaccine Sales Share by Type (2011-2016)
Figure United States Dendritic Cell Cancer Vaccine Sales Market Share by Type in 2015
Table United States Dendritic Cell Cancer Vaccine Revenue and Market Share by Type (2011-2016)
Table United States Dendritic Cell Cancer Vaccine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Dendritic Cell Cancer Vaccine by Type (2011-2016)
Table United States Dendritic Cell Cancer Vaccine Price by Type (2011-2016)
Figure United States Dendritic Cell Cancer Vaccine Sales Growth Rate by Type (2011-2016)
Table United States Dendritic Cell Cancer Vaccine Sales by Application (2011-2016)
Table United States Dendritic Cell Cancer Vaccine Sales Market Share by Application (2011-2016)
Figure United States Dendritic Cell Cancer Vaccine Sales Market Share by Application in 2015
Table United States Dendritic Cell Cancer Vaccine Sales Growth Rate by Application (2011-2016)
Figure United States Dendritic Cell Cancer Vaccine Sales Growth Rate by Application (2011-2016)
Table 3M Company Basic Information List
Table 3M Company Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure 3M Company Dendritic Cell Cancer Vaccine Sales Market Share (2011-2016)
Table Activartis Basic Information List
Table Activartis Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Activartis Dendritic Cell Cancer Vaccine Sales Market Share (2011-2016)
Table Batavia Bioservices Basic Information List
Table Batavia Bioservices Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Batavia Bioservices Dendritic Cell Cancer Vaccine Sales Market Share (2011-2016)
Table Creagene Basic Information List
Table Creagene Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Creagene Dendritic Cell Cancer Vaccine Sales Market Share (2011-2016)
Table Dendreon Basic Information List
Table Dendreon Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dendreon Dendritic Cell Cancer Vaccine Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Dendritic Cell Cancer Vaccine Sales Market Share (2011-2016)
Table Northwest Biotherapeutics Basic Information List
Table Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales Market Share (2011-2016)
Table Glaxo Smith Kline Basic Information List
Table Glaxo Smith Kline Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Glaxo Smith Kline Dendritic Cell Cancer Vaccine Sales Market Share (2011-2016)
Table ImmunoCellular Therapeutics Basic Information List
Table ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Sales Market Share (2011-2016)
Table Tella Incorporation Basic Information List
Table Tella Incorporation Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Tella Incorporation Dendritic Cell Cancer Vaccine Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Dendritic Cell Cancer Vaccine
Figure Manufacturing Process Analysis of Dendritic Cell Cancer Vaccine
Figure Dendritic Cell Cancer Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Dendritic Cell Cancer Vaccine Major Manufacturers in 2015
Table Major Buyers of Dendritic Cell Cancer Vaccine
Table Distributors/Traders List
Figure United States Dendritic Cell Cancer Vaccine Production and Growth Rate Forecast (2016-2021)
Figure United States Dendritic Cell Cancer Vaccine Revenue and Growth Rate Forecast (2016-2021)
Table United States Dendritic Cell Cancer Vaccine Production Forecast by Type (2016-2021)
Table United States Dendritic Cell Cancer Vaccine Consumption Forecast by Application (2016-2021)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *